Key stats
Market capitalization
1.711BINR
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
13.70
Basic EPS (TTM)
7.80INR
About MANGALAM DRUGS & ORGANICS LTD
ISIN
INE584F01014
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
mangalamdrugs.com
CEO
Govardhan Murlidhar Dhoot
Headquarters
Mumbai
Employees
479
Founded
1972
Mangalam Drugs & Organics Ltd. engages in the manufacture of drugs, medicines and allied products. Its products include Acyclovir, Amodiaquine HCI, Bisoprolol Fumarate, Furosemide, Tenofovir Disoproxil Base, Lumefantrine, Bictegravir Sodium and Artemether. The company was founded in 1972 and is headquartered in Mumbai, India.
MANGALAM Inverse HNS Pattern forming??NSE:MANGALAM BSE:MANGALAM
Time Frame – Weekly
Observations :-
* Consolidation & Range formation going on above weekly 200 SMA in 95-197 zone
* Inverse HNS Pattern formation seen on weekly/monthly time frame
* Since last 3 months consolidating in 163-135 range
* Taking good support of Weekly
MANGALAM | INCOMING BREAKOUTMangalam Drugs has been attempting to break the 155 level, with its previous attempts getting rejected. But this time, with the solid foundation of a Double Bottom base, & a Symmetrical Triangle formed near the resistance zone, the chances of a successful breakout increases.
Following points to no
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0